Tumor-homing Bispecific Antibodies that Co-engage EPHA2 and Frizzled Receptors Target RNF43-mutant Pancreatic Cancer and Minimize Toxicity

Disease and Therapeutics · Elsevier

The publisher did not provide an abstract — full text is available via the link below.

Read at publisher →

Similar articles